Published in Mem Inst Oswaldo Cruz on October 12, 2000
Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol (1991) 5.99
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect Immun (1986) 3.80
Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med (1984) 3.49
Plasmid-determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae. J Antimicrob Chemother (1983) 2.54
Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A (1984) 2.52
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol (1987) 2.27
MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG. Int Arch Allergy Appl Immunol (1986) 2.25
Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (1987) 1.85
[In vitro activity of BRL 25.000 (amoxycillin plus clavulanic acid) against Enterobacteriaceae betalactamase producers (author's transl)]. Med Clin (Barc) (1982) 1.83
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med (1979) 1.79
Multiprimer PCR system for differential identification of mycobacteria in clinical samples. J Clin Microbiol (1996) 1.68
Species-specific identification of Mycobacterium bovis by PCR. Microbiology (1995) 1.68
Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence. Infect Immun (1991) 1.63
SHV-1 beta-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob Agents Chemother (2001) 1.54
Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol (1983) 1.53
An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med (1985) 1.52
Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A (1986) 1.51
Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol (1985) 1.46
Inefficacy of burst-suppression anesthesia in medication-resistant major depression: a controlled trial. J ECT (2001) 1.43
Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg (1992) 1.41
Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol (1996) 1.39
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Frequency of plasmid-determined beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae. Eur J Clin Microbiol (1985) 1.35
Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol (1984) 1.32
A species-specific nucleotide sequence of Mycobacterium tuberculosis encodes a protein that exhibits hemolytic activity when expressed in Escherichia coli. Infect Immun (1995) 1.21
Identification of a gene for Cyt1A-like hemolysin from Bacillus thuringiensis subsp. medellin and expression in a crystal-negative B. thuringiensis strain. Appl Environ Microbiol (1997) 1.18
Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A (1995) 1.15
Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature (1979) 1.15
Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae. Infection (1984) 1.11
T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun (2001) 1.11
Amplification of a 500-base-pair fragment from cultured isolates of Mycobacterium bovis. J Clin Microbiol (1999) 1.10
Regulation of the immune response in Plasmodium falciparum malaria. I. Non-specific proliferative responses in vitro and characterization of lymphocytes. Clin Exp Immunol (1983) 1.10
Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci (2003) 1.05
Viral hepatitis in Colombia: a study of the "hepatitis of the Sierra Nevada de Santa Marta". Hepatology (1985) 1.05
Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course. Infect Immun (1991) 1.05
Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. Vaccine (2004) 1.02
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immun (1999) 1.01
Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett (1995) 1.00
Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein. Vaccine (2000) 1.00
Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. Eur J Endocrinol (2005) 0.99
Identification of Mycobacterium bovis in bovine clinical samples by PCR species-specific primers. Can J Vet Res (1999) 0.99
Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotides. Parasite Immunol (1991) 0.98
Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol (1996) 0.98
Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86). Vet Immunol Immunopathol (2002) 0.98
Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp. J Antimicrob Chemother (1989) 0.97
[Is a preanesthetic interview by a team including nurses effective, safe, and efficient?]. Rev Esp Anestesiol Reanim (2007) 0.97
Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization. Exp Parasitol (1999) 0.97
Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro. Clin Exp Immunol (1987) 0.96
Characterization and localization of Plasmodium falciparum surface antigens on infected erythrocytes from west African patients. Blood (1991) 0.95
Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol Biochem Parasitol (1992) 0.94
Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates. Exp Parasitol (2000) 0.93
Isolation and identification of mycobacteria in New World primates maintained in captivity. Vet Microbiol (2004) 0.93
Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis. Immunol Lett (1995) 0.91
Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis. Clin Exp Immunol (1996) 0.91
Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine (2001) 0.91
Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am J Trop Med Hyg (1990) 0.90
Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J Immunol (2001) 0.90
Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis. Clin Exp Immunol (1999) 0.89
Geographical distribution of Plasmodium falciparum erythrocyte rosetting and frequency of rosetting antibodies in human sera. Am J Trop Med Hyg (1990) 0.89
During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins. Clin Exp Immunol (1995) 0.88
Plasmodium falciparum: red blood cell binding studies of peptides derived from histidine-rich KAHRP-I, HRP-II and HRP-III proteins. Acta Trop (2000) 0.87
Immunogenic synthetic peptides against mycobacteria of potential immunodiagnostic and immunoprophylactic value. Lepr Rev (1986) 0.87
The introduction into bacillus sphaericus of the Bacillus thuringiensis subsp. medellin Cyt1Ab1 gene results in higher susceptibility of resistant mosquito larva populations to B. sphaericus. Appl Environ Microbiol (1998) 0.87
Cloning, expression and toxicity of a mosquitocidal toxin gene of Bacillus thuringiensis subsp. medellin. Mem Inst Oswaldo Cruz (1998) 0.87
Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells. Parasitology (2000) 0.87
[Studies on antibacterial activity of cephotaxime (HR 756), a new antibiotic of the cephalosporin group (author's transl)]. Med Clin (Barc) (1980) 0.87
Quantum chemical analysis of MHC-peptide interactions for vaccine design. Mini Rev Med Chem (2010) 0.86
Pit-1/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line. J Endocrinol (2002) 0.86
Vitamin D receptor gene expression in human pituitary gland. Life Sci (1997) 0.85
[Antibacterial spectrum of mezlocillin and azlocillin, two new antibiotics of the ureidopenicillin group (author's transl)]. Med Clin (Barc) (1982) 0.84
Sequence and diversity of MHC DQA and DQB genes of the owl monkey Aotus nancymaae. Immunogenetics (2000) 0.84
Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine (2001) 0.84
Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin Exp Immunol (2001) 0.84
Sequence and diversity of DRB genes of Aotus nancymaae, a primate model for human malaria parasites. Immunogenetics (2000) 0.83
Specific interactions of synthetic peptides derived from P. falciparum merozoite proteins with human red blood cells. Pept Res (1992) 0.83
Shifting the polarity of some critical residues in malarial peptides' binding to host cells is a key factor in breaking conserved antigens' code of silence. Med Chem (2008) 0.83
Diversity of Colombian strains of Bacillus thuringiensis with insecticidal activity against dipteran and lepidopteran insects. J Appl Microbiol (2007) 0.83
Plasmodium falciparum EBA-140 kDa protein peptides that bind to human red blood cells. J Pept Res (2003) 0.83
Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion. J Pept Res (2000) 0.83
Mapping of antigenic determinants of the T. cruzi hsp70 in chagasic and healthy individuals. Mol Immunol (1993) 0.83
[Incidence of nutritional support complications in critical patients: multicenter study]. Nutr Hosp (2011) 0.83
Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres. Vaccine (2002) 0.82
Mapping of the linear antigenic determinants of the Leishmania infantum hsp70 recognized by leishmaniasis sera. Immunol Lett (1996) 0.82
Activation pattern and toxicity of the Cry11Bb1 toxin of Bacillus thuringiensis subsp. medellin. J Invertebr Pathol (2000) 0.82
Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development. Curr Med Chem (2007) 0.81
Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin Exp Immunol (1991) 0.81
Cultivation and characterization of stable Leishmania guyanensis complex axenic amastigotes derived from infected U937 cells. Am J Trop Med Hyg (2001) 0.81
Identification of a particular B cell alloantigen associated with susceptibility to lepromatous leprosy. Lepr Rev (1981) 0.81
A theoretical model of the tridimensional structure of Bacillus thuringiensis subsp. medellin Cry 11Bb toxin deduced by homology modelling. Mem Inst Oswaldo Cruz (2001) 0.81
Malaria vaccines. Curr Opin Immunol (1995) 0.81
High-affinity binding sites to the vitamin D receptor DNA binding domain in the human growth hormone promoter. Biochem Biophys Res Commun (1998) 0.81
Immigration of Bacillus thuringiensis to bean leaves from soil inoculum or distal plant parts. J Appl Microbiol (2007) 0.81
In vitro evaluation of trichoderma and gliocladium antagonism against the symbiotic fungus of the leaf-cutting ant Atta cephalotes. Mycopathologia (2001) 0.80
Immunoglobulin kappa light-chain V, J, and C gene sequences of the owl monkey Aotus nancymaae. Immunogenetics (2000) 0.80
Distribution and characterization of Bacillus thuringiensis on the phylloplane of species of piper (Piperaceae) in three altitudinal levels. Microb Ecol (2002) 0.80
Incidence of strains producing plasmid determined beta-lactamases among carbenicillin resistant Pseudomonas aeruginosa. J Antimicrob Chemother (1986) 0.80
Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages. J Pept Res (2001) 0.80
Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region. Mol Biochem Parasitol (2001) 0.80